Whether a switch is safe depends on the cause of deficiency, symptoms, absorption, previous response, dose, adherence and follow-up
Injection-site and quality-control risk Reported injection-site issues include redness, mild swelling, transient bruising, and occasional sterile abscess
Research-Only Status BPC 157 is designated for research purposes only in most jurisdictions
Starting with BPC-157 alone and adding TB-500 if response plateaus offers a practical strategy for many runners
Using a properly dosed, well-formulated GHK-Cu product consistently is what allows the cumulative effect to occur.
If you have any further questions on the use of this medicine, ask your doctor or nurse